Infant vaccine safety and immune response study
Part of Immune system & allergy clinical trials.
This study tests a combined vaccine for six diseases in infants 6-11 weeks old. It aims to check if the vaccine is safe and helps babies build protection against diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 6 and 11 weeks old.
- Your baby was born at full term (between 37 and 42 weeks of pregnancy).
- Your baby weighed more than 5.5 pounds (2.5 kg) at birth.
- You or a legal guardian are willing to sign a consent form and follow the study schedule.
- Your baby does not have a known allergy to any vaccine ingredients.
- Your baby has not received certain treatments or vaccines within the past week or month (study staff will check this).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests how well an in-house hepatitis B vaccine works in people’s bodies and whether it’s safe. It may help confirm the vaccine’s effectiveness for people in Indonesia, including children and adults.
This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.
This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
This study tests an experimental vaccine (BK1803) to see if it is safe and effective in healthy infants aged 2 to 6 months. It may help protect against several serious diseases.
This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.
Hear when a new Vaccine Adverse Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.